ARCHIVES

Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992

In Brief: Mary Lasker To Be Named To NIH Director’s Advisory Committee; Amos Appointment Official

July 18, 1980

Taxol Issue Prompts Questions Forom Reader

July 26, 1991

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

RFA/PA/Drug Group Announcement Limited

May 6, 1988